These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8037503)

  • 1. HLA antigens in Japanese patients with high titre anti-ribonucleoprotein antibodies.
    Kawai T; Tani K; Okubo T; Suzuki H; Okamura A; Minami M; Katoh K
    Ann Rheum Dis; 1994 Jun; 53(6):426-7. PubMed ID: 8037503
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.
    Smolen JS; Klippel JH; Penner E; Reichlin M; Steinberg AD; Chused TM; Scherak O; Graninger W; Hartter E; Zielinski CC
    Ann Rheum Dis; 1987 Jun; 46(6):457-62. PubMed ID: 3498447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus.
    Fisher DE; Reeves WH; Wisniewolski R; Lahita RG; Chiorazzi N
    Arthritis Rheum; 1985 Dec; 28(12):1348-55. PubMed ID: 2417607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice with purified U1 small nuclear ribonucleoprotein (RNP) induces a pattern of antibody specificities characteristic of the anti-Sm and anti-RNP autoimmune response of patients with lupus erythematosus, as measured by monoclonal antibodies.
    Reuter R; Lührmann R
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8689-93. PubMed ID: 2430297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus. Antibodies to ribonuclear proteins.
    Reichlin M
    Rheum Dis Clin North Am; 1994 Feb; 20(1):29-43. PubMed ID: 8153403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to ribonucleoproteins.
    Hardin JA; Mimori T
    Clin Rheum Dis; 1985 Dec; 11(3):485-505. PubMed ID: 2934209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens.
    Jiang C; Deshmukh US; Gaskin F; Bagavant H; Hanson J; David CS; Fu SM
    J Immunol; 2010 Jan; 184(2):1085-91. PubMed ID: 20007529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antibodies to Sm (Smith) and RNP (ribonucleoprotein) in patients with rheumatic diseases.
    Tsay GJ; Su CB; Chen TY; Lin CS
    Taiwan Yi Xue Hui Za Zhi; 1984 May; 83(5):436-43. PubMed ID: 6332172
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of precipitating antibodies to soluble cellular antigens and histologically defined renal lesions in systemic lupus erythematosus.
    Venables PJ; Yi T; Woodrow DF; Moss J; Maini RN
    Ann Rheum Dis; 1983 Feb; 42(1):17-22. PubMed ID: 6830321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special antibodies for the study of systemic lupus erythematosus: an analysis.
    Tan EM
    Arthritis Rheum; 1982 Jul; 25(7):753-6. PubMed ID: 6980650
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased anti-Sm antibodies in schizophrenic patients and their families.
    Sirota P; Firer M; Schild K; Zurgil N; Barak Y; Elizur A; Slor H
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):793-800. PubMed ID: 8255987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic independency of anti-dsDNA and anti-Sm antibodies in SLE sera.
    Kubota T; Dang H; Takei M; Miyasaka N; Kanai Y; Talal N
    Clin Exp Rheumatol; 1989; 7(5):572-3. PubMed ID: 2591135
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Peredo RA; Santaella ML; Vilá S
    Lupus; 2006; 15(12):892-8. PubMed ID: 17211998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies.
    Harley JB; Gaither KK
    Rheum Dis Clin North Am; 1988 Apr; 14(1):43-56. PubMed ID: 2969602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.
    Eisenberg RA; Dyer K; Craven SY; Fuller CR; Yount WJ
    J Clin Invest; 1985 Apr; 75(4):1270-7. PubMed ID: 3872886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent expression of autoantibodies in systemic lupus erythematosus.
    McCarty GA; Rice JR; Bembe ML; Pisetsky DS
    J Rheumatol; 1982; 9(5):691-5. PubMed ID: 6983576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of Sm antibodies and clinical symptoms in systemic lupus erythematosus].
    Serfling U; Brenke A; Ziegler H; Barthelmes H; Sönnichsen N
    Dermatol Monatsschr; 1988; 174(11):667-70. PubMed ID: 3264793
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic value of anti-RNP/Sm and anti-Ro/La antibodies in lupus nephropathy].
    López-Longo FJ; López-Gómez JM; Jofre Ibáñez R; Escalona M; Rodríguez-Mahou M
    Rev Clin Esp; 1992 Nov; 191(7):354-9. PubMed ID: 1475460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-Sm antibodies--marker antibodies in systemic lupus erythematosus (SLE)].
    Hiepe F; Riemekasten G; von Mikecz A
    Z Rheumatol; 2002 Jun; 61(3):306-7. PubMed ID: 12219637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.